Notably, our study findings obtained through both bioinformatics analysis and immunohistochemistry (IHC) indicated that increased SEC61G expression levels are significantly correlated with poorer clinicopathologic factors in oral squamous cell carcinoma (OSCC). Here, SEC61G is linked to oral cavity squamous cell carcinoma.